Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,175,246
+$426,392 QoQ
Shares Held
97,940
+1.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 245 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. DYN ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in DYN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,175,246 | 97,940 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,748,854 | 96,462 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,310,465 | 118,122 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,365,882 | 107,975 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $747,633 | 78,533 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $716,226 | 68,473 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,613,034 | 68,465 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,823,576 | 106,447 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,129,185 | 60,334 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,252,026 | 44,101 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $322,843 | 24,274 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $215,863 | 24,092 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $275,625 | 24,500 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $123,309 | 10,704 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $120,790 | 10,422 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $132,358 | 10,422 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $87,640 | 12,757 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $76,907 | 7,978 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $94,857 | 7,978 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $129,562 | 7,978 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,556 | 3,401 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $26,649 | 1,716 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $31,017 | 1,477 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,994 | 495 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||